FLASH SPRING SALE: 50% Off Premium Subscription >> FLASH SPRING SALE: 50% Off Premium >>
$0.759
+0.0067 (+0.89%)
At Close: May 01, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.631 $0.95 Wednesday, 1st May 2024 CARA stock ended at $0.759. This is 0.89% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 7.53% from a day low at $0.723 to a day high of $0.777.
90 days $0.515 $1.15
52 weeks $0.500 $4.67

Historical Cara Therapeutics prices

Date Open High Low Close Volume
Jan 14, 2022 $11.70 $11.99 $11.58 $11.95 307 400
Jan 13, 2022 $11.89 $12.01 $11.61 $11.65 271 900
Jan 12, 2022 $12.33 $12.36 $11.91 $11.93 245 500
Jan 11, 2022 $11.99 $12.37 $11.99 $12.29 348 300
Jan 10, 2022 $11.76 $12.16 $11.53 $12.13 498 100
Jan 07, 2022 $11.73 $11.98 $11.62 $11.76 431 900
Jan 06, 2022 $11.70 $11.93 $11.50 $11.66 301 800
Jan 05, 2022 $12.49 $12.66 $11.65 $11.67 516 200
Jan 04, 2022 $12.70 $12.97 $12.34 $12.48 356 767
Jan 03, 2022 $12.30 $12.77 $12.16 $12.65 385 031
Dec 31, 2021 $12.34 $12.58 $12.16 $12.18 328 501
Dec 30, 2021 $12.21 $12.75 $12.04 $12.34 433 099
Dec 29, 2021 $12.32 $12.40 $12.10 $12.21 349 539
Dec 28, 2021 $12.51 $12.65 $12.23 $12.25 319 074
Dec 27, 2021 $12.68 $12.76 $12.46 $12.57 294 558
Dec 23, 2021 $12.38 $12.73 $12.18 $12.66 396 252
Dec 22, 2021 $12.29 $12.48 $12.14 $12.27 312 919
Dec 21, 2021 $12.29 $12.51 $12.18 $12.29 417 571
Dec 20, 2021 $12.38 $12.40 $11.95 $12.21 630 868
Dec 17, 2021 $12.05 $12.67 $11.85 $12.45 1 560 397
Dec 16, 2021 $12.48 $12.52 $12.05 $12.18 598 021
Dec 15, 2021 $11.97 $12.50 $11.62 $12.48 668 911
Dec 14, 2021 $12.02 $12.17 $11.77 $11.99 425 935
Dec 13, 2021 $12.27 $12.35 $11.93 $12.18 515 253
Dec 10, 2021 $12.52 $12.66 $12.07 $12.10 438 065
Click to get the best stock tips daily for free!

About Cara Therapeutics

Cara Therapeutics Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of mod... CARA Profile

Golden Star

Ticker Date Change Price
ETSY Apr 26 1.84% $67.43
DHT Apr 24 1.24% $11.28
LPLA Apr 19 2.49% $262.59
MLI Apr 19 6.77% $52.28
PFLT Apr 18 1.07% $11.25
DOOR Apr 18 0.88% $131.39
LNG Apr 17 0.644% $156.81
FCN Apr 16 2.99% $207.62
ELV Apr 16 4.26% $506.97
ITCI Apr 05 4.92% $68.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT